A multi-centre double-blind controlled trial of glucagon and insulin therapy for severe acute hepatitis
- 10 Downloads
A cooperative study was conducted to determine the efficacy of one week of treatment with infusion of 1 mg glucagon and 10 units insulin twice daily in severe acute hepatitis. Ninty-eight patients with either prothrombin time less than 60% or thrombotest or hepaplastin test less than 50% of normal were randomly assigned to hormone or placebo treatment. SGOT and SGPT values dropped after treatment with a gradual decrease or increase in total serum bilirubin or cholesterol levels similarly in both groups receiving hormone or placebo. Deranged prothrombin time improved more rapidly in the hormone group than in the placebo group. Glucagon and insulin infusion may stimulate recovery of the liver from injury.
Key wordsacute hepatitis glucagon insulin prothrombin time
Unable to display preview. Download preview PDF.
- 10.De Diego JA, Molina LM, Bujan J, et al: Influence of the conjoint administration of insulin and glucagon upon hepatic regeneration. Surg Gynecol Obstet 1986;163:443–447Google Scholar
- 13.Oka H, Okita K, Fujiwara K: Glucagon and insulin therapy in fulminant hepatic failure in Japan. In:Picazo J, ed. Glucagon in Gastroenterology and Hepatology. Pharmacological, Clinical, and Terapeutic Implications. MTP Press Limited, Lancaster. 1982; 171–180Google Scholar
- 15.Wintrobe MM: Blood coagulation. In:Clinical Hematology. Lea & Febiger, Philadelphia. 1981;405–52Google Scholar